Neopharmsp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2016-09-29
Share capital
7,450.00 PLN
Registered address
ul. Solec 38/10, 00-394 Warszawa, Poland

Financials

Filing timeliness

No financial statement for 2019 – the filing deadline has passed. 1 of 1 financial statements was filed late (for 2018, 1 day late).

  • 2019not filed
  • 201816/07/2019
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2018.

Industry · Wholesale of pharmaceutical goods1,118 / 1,550
Top 72%
Division · Wholesale trade19,762 / 28,995
Top 68%
Sector · Wholesale and retail trade; repair of motor vehicles including motorcycles29,039 / 42,239
Top 69%
Voivodeship · Mazowieckie72,833 / 142,031
Top 51%
Country · Poland262,857 / 495,850
Top 53%

Results vs industry

Revenue
This companyUSD 158.26kMedianUSD 1.07mAverageUSD 22.38m
Net profit
This companyUSD -136.00kMedianUSD 37.33kAverageUSD 879.18k
Operating costs
This companyUSD 282.58kMedianUSD 926.31kAverageUSD 21.06m
Assets
This companyUSD 99.18kMedianUSD 609.81kAverageUSD 11.84m

Industry

Trademarks

Neopharm currently holds no active trademarks with the Polish Patent Office. 8 marks have expired or were not registered. The first mark was filed in 2002.

MarkNumberClassesStatusProtected until
TAPIR(word)Z.2952155Not registered –
CARD PLUS(word)Z.2936945Not registered –
ROTOMYCIN(word)Z.2921265Not registered –
SARTAN(word)Z.2880845Proceedings discontinued –
RAMI PLUS(word)Z.2880855Proceedings discontinued –
MarkProtected until
TAPIR(word)–
CARD PLUS(word)–
ROTOMYCIN(word)–
SARTAN(word)–
RAMI PLUS(word)–

Authorized Representatives

Paweł Janaszek – President of the Management Board

Manner of representation

Each member of the management board is authorized to make declarations on behalf of the company independently.

Ownership

OwnerSharesShare valueStake
Genexy sp. z o.o.
74$999.4649.6644%
Monika Włodarczykage 39
66$891.4144.2953%
Others
9$121.566.0403%

Beneficial owners

No beneficial owners recorded for the company Neopharm.

Debt

5 closed proceedings recorded in KRZ history.

Registration dateProceeding typeStatus
Jul 21, 2022
Discontinued enforcement proceedings
Closed
Jul 21, 2022
Discontinued enforcement proceedings
Closed
Jul 21, 2022
Discontinued enforcement proceedings
Closed
Jul 21, 2022
Discontinued enforcement proceedings
Closed
Jul 21, 2022
Discontinued enforcement proceedings
Closed

MSiG notices

Publication dateEvent
Mar 8, 2021Dissolution without liquidation opened

Public aid

PurposeGross amount
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$930
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$16

Competitors

Name
Aimedicalsp. z o.o.
Vorwarts Pharmasp. z o.o.
Black & Whitesp. z o.o.
Osteoprofsp. z o.o.
THC PharmaS.A.
EDGE Pharmasp. z o.o.
Arcade Internationalsp. z o.o.
Filicosp. z o.o.
Get Ready Wheelchairssp. z o.o.
Jacek Waksmundzki Trust 2S.K.A.

Change history

DateEvent
2019-01-17Address change
2017-03-10Share capital increase
2017-03-01Name change
2017-03-01PKD change
2016-09-29Entered in the register

FAQ

Last updated: 2026-04-19